Vieworks , a medical and industrial imaging solutions company, announced on the 13th that it recorded consolidated sales of KRW 239.3 billion and operating profit of KRW 21.4 billion in 2025. Sales increased 7.4% year-on-year, reaching the highest level since the company's founding. However, operating profit decreased 4.1% year-on-year due to increased expenses related to subsidiary expansion and new business R&D.
By business segment, still image X-ray detectors recorded sales of KRW 102.5 billion, video X-ray detectors KRW 38.4 billion, non-destructive testing (NDT) X-ray detectors KRW 25.9 billion, and industrial cameras KRW 47.2 billion, driving overall growth. In particular, NDT X-ray detectors grew 43.9% year-over-year due to increased demand for battery inspection and ship and pipeline inspection. Industrial cameras recorded sales of 11.4%, driven by increased demand for AI semiconductors and high-bandwidth memory (HBM) inspection.
Vieworks plans to expand its digital slide scanner business by supplying its products to the North American and European markets and diversifying its product lineup for research and clinical diagnostics, thereby expanding its market share. Furthermore, as part of its shareholder return policy, the company has decided to pay a cash dividend of KRW 6.2 billion (KRW 690 per share) and will cancel all 388,589 treasury shares, further enhancing its per-share value.
A Vieworks representative stated, “2025 was the year we expanded our unrivaled imaging technology into the industrial and bio-diagnostic fields,” and added, “This year, we will continue our growth path by leading the way with innovative products such as next-generation interface industrial cameras and digital pathology diagnosis solutions.”
- See more related articles
You must be logged in to post a comment.